Osteoclast-like cells in soft tissue leiomyosarcomas

Virchows Archiv

Volumn 456, Issue 3, 2010, Pages 317-323

  Gibbons, C L M H ^a   Sun, S G ^a   Vlychou, M ^a   Kliskey, K ^a   Lau, Y S ^a   Sabokbar, A ^a   Athanasou, N A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Bone resorption; Giant cells; Leiomyosarcoma; Osteoclasts; RANKL

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALDESMON; CD14 ANTIGEN; CD45 ANTIGEN; CD51 ANTIGEN; CD68 ANTIGEN; COLONY STIMULATING FACTOR 1; DESMIN; HLA DR ANTIGEN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TNFRSF11B PROTEIN, HUMAN; TNFSF10 PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; FEMALE; GIANT CELL; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; MACROPHAGE; MALE; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOFT TISSUE LEIOMYOSARCOMA; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; BIOSYNTHESIS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SOFT TISSUE TUMOR;

ADULT; AGED; FEMALE; GIANT CELLS; HUMANS; LEIOMYOSARCOMA; MACROPHAGES; MALE; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; SOFT TISSUE NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 77949731786     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-010-0882-z     Document Type: Article

References (41)

1. Evans HL, Shipley J (2002) Leiomyosarcoma. In: Fletcher DCM, Ummi KK, Merters F (eds) Pathology and genetics of tumours of soft tissue and bone. IARC, Lyon, pp 131-134
2. Weiss SW, Goldblum JR (2001) Leiomyosarcoma. In: Weiss SW, Goldblum JR (eds) Enzinger and Weiss's soft tissue tumours, 4th edn. Mosby, St. Louis, pp 727-748
3. AJ Darby L Papadaki JO Beilby 1975 An unusual leiomyosarcoma of the uterus containing osteoclast like giant cells Cancer 360 495 504 10.1002/1097-0142(197508)36:2<495::AID-CNCR2820360228>3.0.CO;2-I
4. TJ Matthews C Fisher 1994 Leiomyosarcoma of soft tissue and pulmonary metastasis, both with osteoclast like giant cells J Clin Pathol 47 370 371 10.1136/jcp.47.4.370 1:STN:280:DyaK2c3pvFyltw%3D%3D 8027381 (Pubitemid 24171711)
5. T Mentzel E Calonie DC Fletcher 1994 Leiomyosarcoma with prominent osteoclast like giant cells: analysis of eight cases closely mimicking the so-called giant cell variant of malignant fibrous histiocytoma Am J Surg Pathol 18 258 265 1:STN:280:DyaK2c7mtFWqsg%3D%3D 8116793 (Pubitemid 24068249)
6. K Watanabe H Hiraki M Ohishi, et al. 1996 Uterine leiomyosarcoma with osteoclast like giant cells: histopathological and cytological observations Pathol Int 46 656 660 10.1111/j.1440-1827.1996.tb03668.x 1:STN:280: DyaK2s%2FmtFyntw%3D%3D 8905874 (Pubitemid 26330738)
7. BR Konety J Singh JC Lyne, et al. 1996 Leiomyosarcoma with osteoclast like giant cells of the spermatic cord. A case report and review of the literature Urol Int 56 259 262 10.1159/000282856 1:STN:280:DyaK28zntlWjtA%3D%3D 8776828 (Pubitemid 26149611)
8. M Katoh H Shigematsu 1999 Leiomyosarcoma of the heart and its pulmonary metastasis, both with prominent osteoclast like multinucleated giant cells expressing tartrate resistant acid phosphatase activity Pathol Int 49 74 78 10.1046/j.1440-1827.1999.00817.x 1:STN:280:DyaK1M3kt1artQ%3D%3D 10227728 (Pubitemid 29421951)
9. T Terada K Endo H Maeta, et al. 2000 Epithelioid leiomyosarcoma with osteoclast like giant cells in the rectum Arch Pathol Lab Med 124 438 440 1:STN:280:DC%2BD3c7ntVyjtQ%3D%3D 10705403 (Pubitemid 30152152)
10. FA Candanedo-Gonzalez T Vela Chavez A Cerbulo Vazquez 2005 Pleomorphic leiomyosarcoma of the adrenal gland with osteoclast like giant cells Endocr Pathol 16 75 81 10.1385/EP:16:1:075 16000850 (Pubitemid 41278318)
11. KA Pulford EM Rigney KJ Micklem, et al. 1989 KPI: a new monoclonal antibody that detects a monocytes/macrophage associated antigen in routinely processed tissue sections J Clin Pathol 42 414 421 10.1136/jcp.42.4.414 1:STN:280:DyaL1M3jsVKhtw%3D%3D 2654191
12. NA Athanasou J Quinn 1990 Immunophenotypic difference between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function J Clin Pathol 43 997 1004 10.1136/jcp.43.12. 997 1:STN:280:DyaK3M%2FptlCmsg%3D%3D 2266187
13. NA Athanasou 1996 The cellular biology of bone resorbing cells J Bone Joint Surg 78A 1096 1112
14. J Quinn A Sabokbar NA Athanasou 1996 Cells of the mononuclear phagocyte series differentiate into osteoclastic lacunar bone resorbing cells J Pathol 179 106 111 10.1002/(SICI)1096-9896(199605)179:1<106::AID-PATH535>3.0.CO;2-H 1:STN:280:DyaK283ps1ymsg%3D%3D 8691334 (Pubitemid 26180087)
15. N Udagawa N Takahashi T Akatsu, et al. 1990 Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow derived stromal cells Proc Natl Acad Sci USA 87 7260 7264 10.1073/pnas.87.18.7260 1:STN:280: DyaK3czosV2rtQ%3D%3D 2169622 (Pubitemid 20325246)
16. Y Fujikawa JMW Quinn A Sabokbar, et al. 1996 The human mononuclear osteoclast precursor circulates in the monocyte fraction Endocrinology 139 4058 4060 10.1210/en.137.9.4058 (Pubitemid 26284685)
17. JM Quinn J Elliott MT Gillespie, et al. 1998 A combination of osteoclast differentiation factor and macrophage colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro Endocrinology 139 4424 4427 10.1210/en.139.10.4424 1:CAS:528:DyaK1cXmsVGmsL0%3D 9751528 (Pubitemid 28513734)
18. NA Athanasou J Quinn D Ferguson, et al. 1991 Bone resorption by macrophage polykaryons of a giant cell tumour of tendon sheath Br J Cancer 63 527 553 1:STN:280:DyaK3M3hsVyisA%3D%3D 1850609
19. AM Flanagan TJ Chambers 1989 Osteoclasts are present in the giant cell variant of malignant fibrous histiocytoma J Pathol 159 53 57 10.1002/path.1711590112 1:STN:280:DyaK3c%2FjvFOquw%3D%3D 2553905
20. YS Lau A Sabokbar CLMH Gibbons, et al. 2005 Phenotypic and molecular studies on giant cell tumours of bone and soft tissues Hum Pathol 36 945 954 10.1016/j.humpath.2005.07.005 1:CAS:528:DC%2BD2MXpvFeis7o%3D 16153456 (Pubitemid 41253379)
21. TT Yang GCML Sabokbar, et al. 2002 Human mesenchymal tumour associated macrophages differentiate into osteoclastic bone resorbing cells J Bone Joint Surg 84B 452 456 10.1302/0301-620X.84B3.11945
22. C Minkin 1982 Bone acid phosphatase tartrate resistant acid phosphatase as a marker of osteoclast function Calcif Tissue Int 34 285 290 10.1007/BF02411252 1:CAS:528:DyaL38XktlKrs74%3D 6809291 (Pubitemid 12060442)
23. MA Horton D Lewis K McNulty, et al. 1985 Monoclonal antibodies to osteoclastoma (giant cell bone tumours): definition of osteoclast specific cellular antigens Cancer Res 45 5663 5669 1:STN:280:DyaL28%2FislyktA%3D%3D 4053038 (Pubitemid 16218570)
24. YS Lau L Danks SG Sun A Sabokbar, et al. 2007 RANKL-dependent and RANKL-independent molecular mechanisms of macrophage-osteoclast differentiation in breast cancer Breast Cancer Res Treat 96 1716 1722 1:CAS:528: DC%2BD2sXlvVShsbo%3D (Pubitemid 47282754)
25. YS Lau SG Sun CMLH Gibbons, et al. 2007 Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma Br J Cancer 89 928 932
26. J Faust DL Lacey P Hunt, et al. 1999 Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors J Cell Biochem 72 67 80 10.1002/(SICI)1097-4644(19990101)72:1<67::AID-JCB8>3.0. CO;2-A 1:CAS:528:DyaK1cXnvVegsrw%3D 10025668 (Pubitemid 28541482)
27. A Potti AK Ganti K Tendulkar, et al. 2004 Determination of vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas and the role of overexpression in leiomyosarcoma J Cancer Res Clin Oncol 130 52 56 10.1007/s00432-003-0504-0 1:CAS:528:DC%2BD3sXps1yhtrc%3D 14600832 (Pubitemid 38161248)
28. LT Van der Ven PJ Roholl T Gloudemans, et al. 1997 Expression of insulin like growth factors (IGFs), their receptors and IGF binding protein3 in normal, benign and malignant smooth muscle tissues Br J Cancer 75 1631 1640 9184179 (Pubitemid 27229054)
29. SS Tabibzadeh D Poubouridis LT May, et al. 1989 Interleukin 6 immunoreactivity in human tumours Am J Pathol 135 427 433 1:STN:280: DyaL1MzptVGnuw%3D%3D 2675620
30. JK Min YM Kim EC Kim, et al. 2003 Vascular endothelial growth factor up regulates expression of receptor activator of NF kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand J Biol Chem 278 39548 39557 10.1074/jbc.M300539200 1:CAS:528:DC%2BD3sXnvFantLs%3D 12893832 (Pubitemid 37248513)
31. SE Aldridge TW Lennard JR Williams, et al. 2005 Vascular endothelial growth factor receptors in osteoclast differentiation and function Biochem Biophys Res Commun 335 793 798 10.1016/j.bbrc.2005.07.145 1:CAS:528: DC%2BD2MXpsVCgurc%3D 16105658 (Pubitemid 41188268)
32. Y Wang S Nishida HZ Elalieh, et al. 2006 Role of IGF1 signaling in regulating osteoclastogenesis J Bone Miner Res 21 1350 1358 10.1359/jbmr.060610 1:CAS:528:DC%2BD28XhtVSrtr3E 16939393 (Pubitemid 44300041)
33. J Rubin CL Ackert Bicknell L Zhu, et al. 2002 IGF1 regulates osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand in vitro and OPG in vivo J Clin Endocrinol Metab 87 4273 4279 10.1210/jc.2002- 020656 1:CAS:528:DC%2BD38XntFOlsLs%3D 12213884
34. GJ Atkins DR Haynes SE Graves, et al. 2000 Expression of osteoclast differentiation signals by stromal elements of giant cell tumours J Bone Miner Res 15 640 649 10.1359/jbmr.2000.15.4.640 1:CAS:528:DC%2BD3cXisFWmtro%3D 10780856
35. LA Ehrlich GD Roodman 2005 The role of immune cells and inflammatory cytokines in Paget's disease and multiple myeloma Immunol Rev 208 252 266 10.1111/j.0105-2896.2005.00323.x 1:CAS:528:DC%2BD28Xks1ehsQ%3D%3D 16313353
36. RD Devlin SV Reddy R Savino, et al. 1998 IL6 mediates the effects of 1L1 or TNF, but not PTHrP or 1, 25(OH)2D3, on osteoclast like cell formation in normal bone marrow cultures J Bone Miner Res 13 393 399 10.1359/jbmr.1998.13.3. 393 1:CAS:528:DyaK1cXhvFGlsLw%3D 9525339 (Pubitemid 28146221)
37. O Kudo A Sabokbar A Pocock, et al. 1998 Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL independent mechanism Bone 32 1 7 10.1016/S8756-3282(02)00915-8 (Pubitemid 36173806)
38. A Mantovani B Botiazzi F Coloth, et al. 1992 The origin and function of tumour associated macrophages Immunol Today 13 265 276 10.1016/0167-5699(92) 90008-U 1:CAS:528:DyaK38XlsVyltrY%3D 1388654
39. S Yamashiro M Takaya T Nishi, et al. 1994 Tumour derived monocyte chemoattractant protein induces intratumoral infiltration of monocyte derived macrophage subpopulation in transplanted rat tumour Am J Pathol 145 856 867 1:CAS:528:DyaK2cXmvFyrsb0%3D 7943176 (Pubitemid 24320603)
40. EK Sloan N Pouliot KL Stanley, et al. 2006 Tumour specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone Breast Cancer Res 8 R20 10.1186/bcr1398 16608535 (Pubitemid 44377911)
41. HC Blair NA Athanasou 2004 Recent advances in osteoclast biology and pathological bone resorption Histol Histopathol 19 189 199 1:CAS:528: DC%2BD2cXjtFyrtb8%3D 14702187